1. Antibody-functionalized gold nanoparticles as tumor-targeting radiosensitizers for proton therapy.
- Author
-
Li S, Bouchy S, Penninckx S, Marega R, Fichera O, Gallez B, Feron O, Martinive P, Heuskin AC, Michiels C, and Lucas S
- Subjects
- Cell Line, Tumor, Cetuximab chemistry, Cetuximab therapeutic use, Humans, Microscopy, Electron, Transmission, Antibodies chemistry, Antibodies therapeutic use, Gold chemistry, Metal Nanoparticles chemistry, Proton Therapy methods, Radiation-Sensitizing Agents chemistry, Radiation-Sensitizing Agents therapeutic use
- Abstract
Aim: This study aimed at developing antibody-functionalized gold nanoparticles (AuNPs) to selectively target cancer cells and probing their potential radiosensitizing effects under proton irradiation., Materials & Methods: AuNPs were conjugated with cetuximab (Ctxb-AuNPs). Ctxb-AuNP uptake was evaluated by transmission electron microscopy and atomic absorption spectroscopy. Radioenhancing effect was assessed using conventional clonogenic assay., Results & Conclusion: Ctxb-AuNPs specifically bound to and accumulated in EGFR-overexpressing A431 cells, compared with EGFR-negative MDA-MB-453 cells. Ctxb-AuNPs enhanced the effect of proton irradiation in A431 cells but not in MDA-MB-453 cells. These data indicate, for the first time, that combining enhanced uptake by specific targeting and radioenhancing effect, using conjugated AuNPs, is a promising strategy to increase cell killing by protontherapy.
- Published
- 2019
- Full Text
- View/download PDF